Background
Methods
Study design and data sources
Study population
Resident-level risk factors
Facility-level risk factors
Pneumonia and influenza hospitalization
Statistical analysis
Results
Descriptive results
Overall study cohort
Characteristics, n (%) | All N = 1,711,497 | Short-stay (< 100 days) N = 1,118,054 | Long-stay (≥100 days) N = 593,443 |
---|---|---|---|
Length of follow-up, days, mean ± SD | 112 ± 200 | 29 ± 20 | 269 ± 278 |
Age at index date, years, mean ± SD | 81.6 ± 8.2 | 80.8 ± 8.1 | 82.9 ± 8.3 |
65–74 | 394,331 (23.0) | 281,767 (25.2) | 112,564 (19.0) |
75–84 | 639,132 (37.3) | 434,977 (38.9) | 204,155 (34.4) |
85+ | 678,034 (39.6) | 401,310 (35.9) | 276,724 (46.6) |
Female sex | 1,191,557 (69.6) | 768,633 (68.8) | 422,924 (71.3) |
Race/ethnicity | |||
Non-Hispanic White | 1,420,689 (83.0) | 943,096 (84.4) | 477,593 (80.5) |
Non-Hispanic Black | 147,231 (8.6) | 81,401 (7.3) | 65,831 (11.1) |
Hispanic | 62,070 (3.6) | 36,682 (3.3) | 25,388 (4.3) |
Location resident was admitted from | |||
Community or home | 124,588 (7.3) | 37,208 (3.3) | 87,380 (14.7) |
Another LTCF or swing beda | 61,435 (3.6) | 19,777 (1.8) | 41,658 (7.0) |
Hospital | 1,486,083 (86.8) | 1,044,083 (93.4) | 442,000 (74.5) |
LTCF admission is new | 1,441,102 (84.2) | 1,019,035 (91.1) | 422,067 (71.1) |
Body mass index, kg/m2 | |||
< 18.5, underweight | 117,888 (6.9) | 76,489 (6.8) | 41,392 (7.0) |
18.5–24.9, normal | 656,364 (38.4) | 424,751 (38.0) | 231,590 (39.0) |
25–29.9, overweight | 480,408 (28.0) | 313,886 (28.1) | 166,511 (28.1) |
≥ 30, obese | 456,890 (26.7) | 302,928 (27.1) | 153,950 (25.9) |
Current tobacco use | 47,959 (2.8) | 24,811 (2.2) | 23,148 (3.9) |
Clinical Characteristics from MDS | |||
Cancer | 141,791 (8.3) | 108,447 (9.7) | 33,344 (5.6) |
Atrial fibrillation or other dysrhythmias | 441,467 (25.8) | 307,971 (27.8) | 133,496 (22.5) |
Coronary artery disease | 452,352 (26.4) | 304,647 (27.3) | 147,705 (24.9) |
Heart failure | 385,850 (22.5) | 243,464 (21.9) | 142,386 (24.0) |
Hypertension | 1,352,541 (79.0) | 877,554 (78.5) | 474,987 (80.0) |
History of pneumonia | 125,660 (7.3) | 104,590 (9.4) | 21,070 (3.6) |
Diabetes mellitus | 554,424 (32.4) | 347,402 (31.1) | 207,022 (34.9) |
Arthritis | 517,064 (30.2) | 339,561 (30.4) | 177,503 (29.9) |
Alzheimer’s disease | 107,700 (6.3) | 35,684 (3.2) | 72,016 (12.1) |
Cerebrovascular accident, transient ischemic attack, or stroke | 197,397 (11.5) | 104,438 (9.3) | 92,959 (15.7) |
Non-Alzheimer’s dementia | 406,597 (23.8) | 165,369 (14.8) | 241,228 (40.7) |
Depression | 595,844 (34.8) | 314,369 (28.1) | 281,475 (47.4) |
Asthma, chronic obstructive pulmonary disease, chronic lung disease | 410,086 (24.0) | 269,238 (24.1) | 140,848 (23.7) |
Respiratory failure | 44,460 (2.6) | 33,858 (3.0) | 10,602 (1.8) |
Parkinson’s disease | 74,036 (4.3) | 36,366 (3.3) | 37,670 (6.4) |
Geriatric Syndromes | |||
Cognitive Function Scale score | |||
Intact/mild cognitive impairment (0–1) | 1,001,934 (58.5) | 778,937 (52.1) | 222,997 (37.6) |
Moderate cognitive impairment (2, 3) | 680,284 (39.8) | 325,810 (29.1) | 354,474 (59.7) |
Severe cognitive impairment (4–6) | 29,274 (1.7) | 13,307 (1.2) | 15,972 (2.7) |
Activities of Daily Living 28-point Scale score | |||
None to limited assistance required (0–14) | 795,028 (46.5) | 582,547 (46.5) | 212,481 (38.5) |
Extensive assistance required (15–19) | 620,211 (36.2) | 385,371 (34.5) | 234,840 (39.5) |
Extensive dependency (≥20) | 296,258 (17.3) | 150,136 (13.4) | 146,122 (24.6) |
CHESS Scale score, overall health stability | |||
No instability (0) | 990,561 (57.9) | 650,661 (58.2) | 339,900 (57.3) |
Minimal instability (1, 2) | 701,695 (41.0) | 456,279 (40.8) | 245,416 (41.4) |
Moderate to very high instability (3+) | 19,241 (1.1) | 11,114 (1.0) | 8127 (1.4) |
Charlson comorbidity score (MDS) | |||
0 | 155,594 (9.1) | 117,051 (10.5) | 38,543 (6.5) |
1–2 | 719,649 (42.1) | 484,120 (43.3) | 235,529 (39.7) |
≥ 3 | 836,254 (48.9) | 516,883 (46.2) | 319,371 (53.8) |
Urinary incontinence: frequent/always | 529,756 (31.0) | 238,989 (21.4) | 290,767 (49.0) |
Bowel incontinence: frequent/always | 403,981 (23.6) | 190,054 (17.0) | 403,981 (23.6) |
Shortness of breath | 258,935 (15.1) | 172,789 (15.5) | 86,146 (14.5) |
Swallowing disorder | 65,162 (3.8) | 46,058 (4.1) | 19,104 (3.2) |
Tube feeding | 33,988 (2.0) | 17,140 (1.5) | 16,848 (2.8) |
Ventilator or respirator use | 1741 (0.1) | 678 (0.1) | 1063 (0.2) |
Prognosis: less than 6 months to live | 7145 (0.4) | 5274 (0.5) | 1871 (0.3) |
Died during study period 2013–2015 | 812,036 (47.4) | 459,028 (41.1) | 353,008 (59.5) |
Medication Use 6 months before index | |||
Beers criteria medication,b any use | 1,098,173 (64.2) | 672,349 (60.1) | 425,824 (71.8) |
Antipsychotics, any use | 96,289 (5.6) | 39,659 (3.6) | 56,630 (9.5) |
Opioid analgesics, any use | 127,139 (7.4) | 99,251 (8.9) | 27,888 (4.7) |
Antibiotics, any usec | 704,363 (41.2) | 461,537 (41.3) | 242,826 (40.9) |
Corticosteroids, any use | 99,079 (5.8) | 72,409 (6.5) | 26,670 (4.5) |
Proton pump inhibitors, any use | 328,345 (19.2) | 229,345 (20.5) | 99,000 (16.7) |
Influenza vaccine received for season of cohort entry | 1,021,615 (59.7) | 628,356 (56.2) | 393,259 (66.3) |
Pneumococcal vaccination up to date | 1,177,063 (68.8) | 749,307 (67.0) | 427,756 (72.1) |
Health Service Use 6 months before index | |||
Any hospitalization use | 1,388,076 (81.1) | 1,037,211 (92.8) | 350,865 (59.1) |
Any ICU use | 454,699 (26.6) | 340,691 (30.5) | 114,008 (19.2) |
Facility Structural Characteristics | |||
Urban location | 1,298,856 (75.9) | 886,434 (79.3) | 412,422 (69.5) |
Total bed size | |||
< 100 | 630,730 (36.9) | 415,999 (37.2) | 214,731 (36.2) |
100–200 | 882,091 (51.5) | 570,832 (51.1) | 311,259 (51.5) |
> 200 | 198,676 (11.6) | 131,223 (11.7) | 67,453 (11.4) |
For-profit facility | 1,159,613 (67.8) | 746,395 (66.8) | 413,218 (69.6) |
Facility Staffing Type and Hours | |||
Ratio of RN to RN + LPN, mean ± SD | 0.4 ± 0.2 | 0.4 ± 0.2 | 0.3 ± 0.2 |
SLP on-staff, hours / 100 Beds, mean ± SD | 0.5 ± 1.6 | 0.6 ± 1.6 | 0.4 ± 1.4 |
LIP on-site | 773,827 (45.2) | 515,034 (46.1) | 258,793 (43.6) |
Total nursing hours/resident/day, mean ± SD | 4.9 ± 9.4 | 5.3 ± 10.5 | 4.3 ± 6.8 |
Facility Care Quality | |||
Antipsychotic use, % of residents, mean ± SD | 18.9 ± 11.2 | 17.2 ± 10.3 | 22.1 ± 12.2 |
Restraint use, % of residents, mean ± SD | 2.0 ± 4.5 | 1.8 ± 4.3 | 2.4 ± 4.8 |
Pressure ulcers, % of residents, mean ± SD | 6.5 ± 4.7 | 6.7 ± 4.8 | 6.2 ± 4.3 |
Days since index date | Short-stay residents (N = 1,118,054) | Long-stay residents (N = 593,443) | ||||
---|---|---|---|---|---|---|
30 | 90 | 30 | 90 | 180 | 365 | |
Total person-days observed | 24,395,364 | 32,290,058 | 15,668,663 | 41,150,984 | 70,681,373 | 111,720,666 |
Primary diagnosis position on the hospital claim | ||||||
Number of hospitalizations | 6345 | 8412 | 5410 | 11,777 | 18,202 | 26,891 |
Crude IR per 100,000 (95% CI) | 26.0 (25.4–26.6) | 26.1 (25.5–26.6) | 34.5 (33.6–35.4) | 28.6 (28.1–29.1) | 25.8 (29.4–30.2) | 24.1 (23.8–24.4) |
Any diagnosis position on the hospital claim | ||||||
Number of hospitalizations | 21,942 | 28,943 | 12,819 | 28,046 | 43,220 | 63,560 |
Crude IR per 100,000 (95% CI) | 89.9 (88.8–91.1) | 89.6 (88.6–90.7) | 81.8 (80.4–83.2) | 68.2 (67.3–69.0) | 61.1 (60.6–61.7) | 56.9 (56.4–57.3) |
Incidence rate
Multivariable results of cox proportional hazards models
Risk factors among long-stay residents
Characteristics | Short-staya HR (99% CI)c | Long-stayb HR (99% CI)c |
---|---|---|
Age group (ref = 65–74) | ||
75–84 | 1.08 (1.00, 1.17) | 1.11 (1.06, 1.15) |
85+ | 1.16 (1.06, 1.27) | 1.23 (1.18, 1.28) |
Sex (ref = male) | 0.84 (0.79, 0.89) | 0.83 (0.80, 0.85) |
Race and ethnicity | ||
Non-Hispanic White (ref = non-White) | 1.00 (0.87, 1.15) | 1.03 (0.97, 1.11) |
Non-Hispanic Black (ref = non-Black) | 0.86 (0.72, 1.03) | 0.89 (0.82, 0.97) |
Hispanic (ref = non-Hispanic) | 1.02 (0.82, 1.27) | 1.05 (0.95, 1.15) |
Location resident is admitted from (ref = hospital) | ||
Community or home | 0.81 (0.67, 0.98) | 0.79 (0.76, 0.83) |
Another LTCF or swing bedd | 0.99 (0.77, 1.26) | 0.92 (0.87, 0.97) |
Other location | 0.78 (0.60, 1.02) | 0.86 (0.81, 0.93) |
Type of admission is reentry (ref = new) | 6.50 (6.09, 6.95) | 1.43 (1.39, 1.47) |
Body mass index, kg/m2 (ref = 18.5–24.9, normal) | ||
< 18.5, underweight | 1.14 (1.03, 1.25) | 1.05 (0.99, 1.11) |
25–29.9, overweight | 0.88 (0.82, 0.95) | 0.98 (0.95, 1.01) |
≥ 30, obese | 0.74 (0.68, 0.81) | 0.98 (0.95, 1.02) |
Current tobacco use (ref = no tobacco use) | 0.87 (0.72, 1.06) | 1.01 (0.95, 1.07) |
Clinical Characteristics from MDS | ||
Cancer | 1.20 (1.10, 1.32) | 1.00 (0.94, 1.07) |
Atrial fibrillation or other dysrhythmias | 1.13 (1.06, 1.21) | 1.05 (1.01, 1.08) |
Coronary artery disease | 1.00 (0.94, 1.07) | 1.01 (0.98, 1.04) |
Heart failure | 1.00 (0.92, 1.08) | 1.13 (1.08, 1.18) |
Hypertension | 1.02 (0.95, 1.10) | 0.99 (0.96, 1.02) |
History of pneumonia | 3.60 (3.36, 3.85) | 1.38 (1.29, 1.46) |
Diabetes mellitus | 0.98 (0.91, 1.05) | 1.02 (0.99, 1.06) |
Arthritis | 0.92 (0.85, 0.98) | 0.95 (0.92, 0.98) |
Alzheimer’s disease | 0.79 (0.67, 0.94) | 0.89 (0.86, 0.93) |
Cerebrovascular accident, transient ischemic attack, or stroke | 0.80 (0.72, 0.89) | 0.89 (0.86, 0.93) |
Non-Alzheimer’s dementia | 0.91 (0.84, 0.99) | 0.87 (0.84, 0.89) |
Depression | 0.98 (0.92, 1.05) | 1.07 (1.05, 1.10) |
Asthma, chronic obstructive pulmonary disease, chronic lung disease | 1.48 (1.38, 1.58) | 1.56 (1.51, 1.61) |
Respiratory failure | 1.11 (0.99, 1.24) | 1.13 (1.03, 1.24) |
Parkinson’s disease | 0.82 (0.69, 0.97) | 0.95 (0.90, 1.00) |
Geriatric Syndromes | ||
Cognitive Function Scale score (ref = no/mild impairment) | ||
Moderate cognitive impairment (2, 3) | 0.95 (0.89, 1.02) | 0.90 (0.87, 0.92) |
Severe cognitive impairment (4–6) | 1.21 (1.01, 1.45) | 0.92 (0.84, 1.01) |
Activities of Daily Living 28-point Scale score (ref = None to limited assistance required) | ||
Extensive assistance required (15–19) | 1.56 (1.45, 1.68) | 1.08 (1.05, 1.11) |
Extensive dependency (≥20) | 1.91 (1.74, 2.08) | 1.08 (1.04, 1.12) |
CHESS Scale score, overall health stability (ref = stable) | ||
Minimal instability (1, 2) | 1.21 (1.12, 1.33) | 1.09 (1.04, 1.14) |
Moderate to very high instability (3+) | 1.04 (0.84, 1.28) | 1.17 (1.04, 1.32) |
Charlson comorbidity score (MDS) (ref = 0) | ||
1–2 | 1.10 (0.96, 1.26) | 1.04 (0.98, 1.10) |
≥ 3 | 1.15 (0.99, 1.34) | 1.12 (1.04, 1.19) |
Urinary or bowel incontinence (ref = none) | 1.11 (1.04, 1.18) | 0.99 (0.96, 1.02) |
Shortness of breath | 2.26 (2.09, 2.43) | 1.34 (1.28, 1.39) |
Swallowing disorder | 0.91 (0.80, 1.03) | 0.96 (0.89, 1.04) |
Tube feeding | 0.90 (0.76, 1.07) | 1.30 (1.20, 1.41) |
Ventilator or respirator use while in facility | 1.48 (0.82, 2.67) | 1.34 (1.03, 1.75) |
Prognosis: less than 6 months to live | 0.88 (0.61, 1.25) | 0.80 (0.62, 1.04) |
Medication Use 6 months before index | ||
Beers Criteria medication,e any use | 1.09 (1.03, 1.16) | 1.09 (1.06, 1.13) |
Antipsychotics, any use | 0.86 (0.74, 1.01) | 0.81 (0.77, 0.86) |
Opioid analgesics, any use | 1.11 (1.01, 1.23) | 0.97 (0.91, 1.03) |
Antibiotics,f any use | 1.15 (1.08, 1.22) | 1.30 (1.27, 1.34) |
Corticosteroids, any use | 1.10 (1.00, 1.22) | 1.10 (1.04, 1.17) |
Proton pump inhibitors, any use | 1.04 (0.97, 1.12) | 0.87 (0.84, 0.91) |
Influenza vaccine received for season of cohort entry | 0.99 (0.92, 1.05) | 1.09 (1.06, 1.13) |
Pneumococcal vaccination up to date | 0.99 (0.92, 1.06) | 1.06 (1.03, 1.10) |
Health Service Use 6 months before index | ||
Any Hospitalizations | 1.04 (0.92, 1.18) | 0.91 (0.88, 0.94) |
Any ICU use | 1.06 (0.99, 1.13) | 1.06 (1.02, 1.11) |
Facility Structural Characteristics | ||
Urban location (ref = non-urban) | 0.87 (0.80, 0.93) | 0.77 (0.74, 0.79) |
Total bed size (ref = < 100) | ||
100–200 | 0.94 (0.88, 1.01) | 0.91 (0.88, 0.94) |
> 200 | 0.93 (0.82, 1.06) | 0.89 (0.84, 0.94) |
For profit facility (ref = not for profit) | 1.01 (0.90, 1.08) | 1.05 (1.02, 1.08) |
Facility Staffing Type and Hours | ||
Ratio of RN to RN + LPN (fifth vs. first quintile) | 0.91 (0.81, 1.02) | 0.90 (0.85, 0.95) |
SLP on-staff hours / 100 Beds (fifth vs. first quintile) | 1.02 (0.94, 1.11) | 0.99 (0.98, 1.00) |
LIP on-site (ref = none) | 1.02 (0.96, 1.08) | 0.93 (0.90, 0.95) |
Total nursing hours/resident/day (fifth vs. first quintile) | 0.87 (0.78, 0.97) | 0.99 (0.95, 1.04) |
Facility Care Quality | ||
Antipsychotic use, % of residents (fifth vs. first quintile) | 1.00 (0.90, 1.10) | 1.07 (1.02, 1.11) |
Restraint use, % of residents (fifth vs. first quintile) | 1.02 (0.94, 1.10) | 1.07 (1.04, 1.11) |
Pressure ulcers, % of residents (fifth vs. first quintile) | 0.96 (0.87, 1.05) | 1.01 (0.96, 1.05) |